Valeant Falls on Report of Federal Probe

Valeant Pharmaceuticals International Inc. fell 6.7 percent following a report that it’s the target of a criminal probe by federal prosecutors, who are investigating whether the drugmaker defrauded insurers by hiding its ties to a mail-order pharmacy. Bloomberg's Cynthia Koons reports on "Bloomberg Markets." (Source: Bloomberg)

SEB's Yokota Sees Further Depreciation in Yuan
35:20 - Sean Yokota, head of Asia strategy at Skandinaviska Enskilda Banken, discusses the yuan and the drivers of economic growth in China. He speaks on "Bloomberg Markets: Asia." (Source: Bloomberg)
  • White House Reassesses Iran Nuclear Deal
  • S&P's Gruenwald Sees BOJ Staying the Course
  • Toshiba's Board Agrees to Sell Chip Unit for $18 Billion